Neuroendocrine Tumors of the Lung: The Role of Surgery in Small Cell Lung Cancer

Thoracic Surgery Clinics

Volumn 24, Issue 3, 2014, Pages 313-326

  Stamatis, Georgios ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Indications; Results; Small cell lung cancer; Staging; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; HISTOPATHOLOGY; HUMAN; INDUCTION CHEMOTHERAPY; LUNG LESION; LUNG SURGERY; LYMPH NODE DISSECTION; MEDIASTINUM LYMPH NODE; MIXED SMALL CELL LUNG CANCER; NEUROENDOCRINE TUMOR; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; SECOND CANCER; SECOND PRIMARY LUNG TUMOR; SMALL CELL LUNG CANCER; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT RESPONSE; INDICATIONS; LUNG RESECTION; LUNG SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE; MEDIASTINUM; PATHOLOGY; RESULTS; STAGING; SURGERY;

INDICATIONS; RESULTS; SMALL CELL LUNG CANCER; STAGING; SURGERY;

HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; MEDIASTINUM; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; SMALL CELL LUNG CARCINOMA;

EID: 84907044862     PISSN: None     EISSN: 15585069     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2014.05.004     Document Type: Review

References (111)

1. Devesa S.S., Bray F., Vizcaino A.P., et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005, 117:294-299.
2. Rostad H., Naalsund A., Jacobsen R., et al. Small cell lung cancer in Norway. Should more patients have been offered surgical therapy?. Eur J Cardiothorac Surg 2004, 26:782-786.
3. Hansen H.H., Dombernowsky P., Hirsch F.R. Staging procedures and prognostic features in small cell lung anaplastic carcinoma. Semin Oncol 1978, 5:280-287.
4. Zelen M. Keynote address on biostatic data retrieval. Cancer Chemother Rep 3 1973, 4:31-42.
5. Travis W.D., Colby T.V., Corrin B., et al. Histologic typing of lung and pleural tumors. World Health Organization international classification of tumors 1999, 7-12. Springen, Berlin.
6. Shepherd F.A., Crowley J., Van Houte P., International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007, 2:1067-1077.
7. Valliéres E., Shepherd F.A., Crowley J., International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathological staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:1049-1059.
8. Goldman K.P. Histology of lung cancer in relation to prognosis. Thorax 1965, 20:298-302.
9. Lennox S.C., Flavell G., Pollock D.J., et al. Results of resection for oat cell carcinoma of the lung. Lancet 1968, 2:925-927.
10. Fox W., Scadding J.G. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of the bronchus. Ten-year follow-up. Lancet 1973, 2(7820):63-65.
11. Szczesny T.J., Szczesna A., Shepherd F.A., et al. Surgical treatment of small cell lung cancer. Semin Oncol 2003, 30:47-56.
12. Livinston R.B. Current CT of small cell lung cancer. Chest 1986, 89:2585-2635.
13. Elliott S.A., Osterlind K., Hirsch F.R., et al. Metastatic patterns in small-cell lung cancer: correlation of autopsy findings and clinical parameters in 537 patients. J Clin Oncol 1987, 5:246-254.
14. Arriagada R., Le Chevalier T., Borie F., et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 1995, 87:183-190.
15. Shepherd F.A., Ginsberg R.J., Patterson G.A., et al. A prospective study of adjuvant surgical resection after CT for limited small cell lung cancer. J Thorac Cardiovasc Surg 1989, 97:177-186.
16. Lad T., Piantadosi S., Thomas P., et al. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination CT. Chest 1994, 106:320-323.
17. Waddell T.K., Shepherd F.A. Should aggressive surgery ever be part of the management of small cell lung cancer?. Thorac Surg Clin 2004, 14:271-281.
18. Shields T.W., Higgins G.A., Matthews M.J., et al. Surgical resection in the management of small cell lung carcinoma of the lung. J Thorac Cardiovasc Surg 1982, 84:481-488.
19. Shields T.W. Surgery of small cell lung cancer. Chest 1986, 89:264S-267S.
20. Weksler B., Nason K.S., Shende M., et al. Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg 2012, 94:889-893.
21. Yu J.B., Decker R.H., Detterbeck F.C., et al. Surveillance Epidemiology and End Results evaluation on the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010, 5:215-219.
22. Califano R., Abidin A.Z., Peck R., et al. Management of small cell lung cancer: recent developments for optimal care. Drugs 2012, 72:471-490.
23. Ferraldeschi R., Baka S., Jyoti B., et al. Modern management of small cell lung cancer. Drugs 2007, 67:2135-2152.
24. Shore D.F., Paneth M. Survival after resection of small cell carcinoma of the bronchus. Thorax 1980, 35:819-822.
25. Sørensen H.R., Lund C., Alstrup P. Survival in small cell lung carcinoma after surgery. Thorax 1986, 41:479-482.
26. Maassen W., Greschuchna D., Martinez I. The role of surgery in the treatment of small cell carcinoma of the lung. Recent results in cancer research 1985, vol. 97:107-115. Springer Verlag Berlin-Heidelberg, Berlin (Germany).
27. Jett J.R., Schild S.E., Kesler K.A., et al. Treatment of small cell lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:400S-419S.
28. Idhe D.C., Pass H.I., Glatstein E.J. Small cell lung cancer. Cancer: principles and practice of oncology 1985, 911-949. Lippincott, Philadelphia:. 5th edition. V.T. DeVita, S. Hellmann, S.A. Rosenberg (Eds.).
29. Pignon J.P., Arriagada R., Idhe D.C., et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992, 327:1618-1624.
30. Elias A.D. Small cell lung cancer: state of the art therapy in 1996. Chest 1997, 112:251S-258S.
31. Gray J.R., Sobczak M.L., Hahn S.M., et al. Analysis of local control in 150 limited stage small cell lung cancer patients treated with combined thoracic irradiation and multiagent CT. Proc Am Soc Clin Oncol 1995, 14:349. [abstract 1056].
32. Souhami R.L., Law K. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. Br J Cancer 1990, 61:584-589.
33. Thomas C.R., Giroux D.J., Janaki L.M., et al. Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small cell lung cancer. Lung Cancer 2001, 33:213-219.
34. Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992, 10:890-895.
35. Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999, 340:265-271.
36. Schreiber D., Rineer J., Weedon J., et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer. Cancer 2010, 116:1350-1357.
37. Hirsch F.R., Osterlind K., Hansen H.H. The prognosis significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patients. Cancer 1983, 52:2144-2150.
38. Carney D.N., Matthews M.J., Ihde D.C., et al. Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival. J Natl Cancer Inst 1980, 65:1225-1230.
39. Choi H., Byhardt R.W., Clowry L.J., et al. The prognostic significance of histologic subtyping in small cell carcinoma of the lung. Am J Clin Oncol 1984, 7:389-397.
40. Mangum M.D., Greco F.A., Hainsworth J.D., et al. Combined small cell and non-small-cell lung cancer. J Clin Oncol 1989, 7:607-612.
41. Shepherd F.A., Ginsberg R.J., Feld R., et al. Surgical treatment for limited small cell lung cancer. The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg 1991, 101:385-393.
42. Shepherd F.A., Ginsberg R., Patterson G.A., et al. Is there ever a role for salvage operations in limited small-cell lung cancer?. J Thorac Cardiovasc Surg 1991, 101:196-200.
43. Yamada K., Saijo N., Kojima A., et al. A retrospective analysis of patients receiving surgery after CT for small cell lung cancer. Jpn J Clin Oncol 1991, 21:39-45.
44. Csekeo A. The possibility of surgery for small cell lung cancer (state of the art). Magy Onkol 2006, 50:223-227.
45. Niho S., Yokose T., Nagai K., et al. A case of synchronous double primary lung cancer with neuroendocrine features. Jpn J Clin Oncol 1999, 29(4):219-225.
46. Nishiyama H., Kaguraoka H., Kuroki M., et al. Multiple primary cancers in surgically resected lung cancer patients. Nihon Kyobu Geka Gakkai Zasshi 1989, 37:56-61.
47. Hiraki A., Ueoka H., Yoshino T., et al. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment. Oncol Rep 1999, 6:75-80.
48. Kondo K., Monden Y. Therapy for multiple primary lung cancers. Kyobu Geka 2002, 55:4-9.
49. Johnson B.E., Contazar P., Chute J.P. Second lung cancers in patients successfully treated for lung cancer. Semin Oncol 1997, 24:492-499.
50. Heyne K.H., Lippmann S.M., Lee J.J., et al. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol 1992, 10:1519-1524.
51. Kawahara M., Ushijima S., Kamimori T., et al. Second primary tumors in more than 2 year disease free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer 1998, 78:409-412.
52. Reinmuth N., Stumpf A., Stumpf P., et al. Characteristics and outcome of patients with second primary lung cancer. Eur Respir J 2012, 42(6):1668-1676. [abstract].
53. Sagman U., Lishner M., Maki E., et al. Second primary malignancies following diagnosis of small-call lung cancer. J Clin Oncol 1992, 10:1525-1533.
54. Szczepek B., Szymanska D., Decker E., et al. Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC). Lung Cancer 1994, 11:93-104.
55. Smythe W.R., Estrera A.L., Swisher S.G., et al. Surgical resection of non-small cell carcinoma after treatment of small cell carcinoma. Ann Thorac Surg 2001, 71:962-966.
56. Soria J.C., Bréchot J.M., Lebeau B., et al. Second primary cancers after small-cell lung cancer. Bull Cancer 1997, 84:800-806.
57. Johnson B.E., Linnolla R.I., Williams J.P., et al. Risk of second aerodigestive cancers increases in patients who survive free of small cell lung cancer for more than 2 years. J Clin Oncol 1995, 13:101-111.
58. Schumacher T., Brink I., Mix M., et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med 2001, 28:483-488.
59. Zhao D.S., Valdivia A.Y., Li Y., et al. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer. Semin Nucl Med 2002, 32:272-275.
60. Kamel E.M., Zwahlen D., Wyss M.T., et al. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003, 44:1911-1917.
61. Bradley J.D., Dehdashti F., Mintun M.A., et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. Clin Oncol 2004, 22(16):3248-3254.
62. Li W., Hammar S.P., Jolly P.C., et al. Unpredictable course of small cell undifferentiated lung carcinoma. J Thorac Cardiovasc Surg 1981, 81:34-43.
63. Shah S.S., Thompson J., Goldstraw P. Results of operation without adjuvant therapy in the treatment of small cell lung cancer. Ann Thorac Surg 1992, 54:498-501.
64. Sundstrøm S., Bremnes R.M., Kaasa S., et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 2002, 20:4665-4672.
65. Laurie S.A., Logan D., Markman B.R., et al. Practice guideline for the role of combination CT in the initial management of limited-stage small-cell lung cancer. Lung Cancer 2004, 43:223-240.
66. McCracken J.D., Janaki L.M., Crowley J.J., et al. Concurrent CT/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. J Clin Oncol 1990, 8:892-898.
67. Hayata Y., Funatsu H., Suemasu K., et al. Surgical indications for small cell carcinoma of the lung. Jpn J Clin Oncol 1978, 8:93-100.
68. Meyer J.A., Comis R.L., Ginsberg S.J., et al. The prospect of disease control by surgery combined with CT in stage I and stage II small cell carcinoma of the lung. Ann Thorac Surg 1983, 36:37-41.
69. Meyer J.A., Gullo J.J., Ikins P.M., et al. Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1984, 88:495-501.
70. Ohta M., Hara N., Ichinose Y., et al. The role of surgical resection in the management of small cell carcinoma of the lung. Jpn J Clin Oncol 1986, 16:289-296.
71. Osterlind K., Hansen M., Hansen H.H., et al. Influence of surgical resection prior to CT on the long-term results in small cell lung cancer. A study of 250 operable patients. Eur J Cancer Clin Oncol 1986, 22:589-593.
72. Maassen W., Greschuchna D. Small cell carcinoma of the lung-to operate or not? Surgical experience and results. Thorac Cardiovasc Surg 1986, 34:71-76.
73. Shepherd F.A., Evans W.K., Feld R., et al. Adjuvant CT following surgical resection for small-cell carcinoma of the lung. J Clin Oncol 1988, 6:832-838.
74. Karrer K., Denck H., Karnicka-Mlodkowska H., et al. The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC). Med Oncol Tumor Pharmacother 1989, 6:143-149.
75. Macchiarini P., Hardin M., Basolo F., et al. Surgery plus adjuvant CT for T1-3N0M0 small-cell lung cancer. Rationale for current approach. Am J Clin Oncol 1991, 14:218-224.
76. Hara N., Ichinose Y., Kuda T., et al. Long-term survivors in resected and nonresected small cell lung cancer. Oncology 1991, 48:441-447.
77. Davis S., Crino L., Tonato M., et al. A prospective analysis of CT following surgical resection of clinical stage I-II small-cell lung cancer. Am J Clin Oncol 1993, 16:93-95.
78. Karrer K., Ulsperger E. Surgery for cure followed by CT in small cell carcinoma of the lung. For the ISC-Lung Cancer Study Group. Acta Oncol 1995, 34:899-906.
79. Lucchi M., Mussi A., Chella A., et al. Surgery in the management of small cell lung cancer. Eur J Cardiothorac Surg 1997, 12(5):689-693.
80. Rea F., Callegaro D., favaretto A., et al. Long term results of surgery and CT in small cell lung cancer. Eur J Cardiothorac Surg 1998, 14:398-402.
81. Shepherd F.A. Surgical management of small-cell lung cancer. Lung cancer: principles and practice 2000, 889-913. Lippincott Williams & Wilkins, Baltimore (MD), Philadelphia: Raven; p. 967-80. H.I. Pass, J.B. Mitchell, D.H. Johnson (Eds.).
82. Cataldo I. Long term survival for resectable small cell lung cancer. Lung Cancer 2000, 29:130-132.
83. Suzuki R., Tsuchiya R., Ichinose Y., et al. Phase II trial of post-operative adjuvant cisplatin/etoposide (PE) in patients with completely resected SCLC. Proc Am Soc Clin Oncol 2000, 19:492a. [abstract 1925].
84. Kobayashi S., Okada S., Hasumi T., et al. Combined modality therapy including surgery for stage III stage III small cell lung cancer on the basis of the sensitivity assay in vitro. Surg Today 2000, 30:127-133.
85. Badzio A., Jassern J., Kurowski K., et al. The role of surgery in limited disease (LD) small cell lung cancer (SCLC): retrospective comparative study. Eur J Cancer 2001, 37:61.
86. Wang H.J., Sun K.L., Zhang X.R., et al. Combined modality therapy for small cell lung cancer patient with limited stage disease. Zhonghua Zhong Liu Za Zhi 2007, 29:701-709.
87. Ju M.H., Kim H.R., Kim J.B., et al. Surgical outcomes in small cell lung cancer. Korean J Thorac Cardiovasc Surg 2012, 45:40-44.
88. Ogawa S., Horio Y., Yatabe Y., et al. Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer. Int J Clin Oncol 2012, 17:218-224.
89. Brock M.V., Hooker C.M., Syphard J.E., et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum CT: its time has come. J Thorac Cardiovasc Surg 2005, 129:64-72.
90. Tsuchiya R., Suzuki K., Ichinose Y., et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 2005, 129:977-983.
91. Bischof M., Debus J., Herfarth K., et al. Surgery and CT for small cell lung cancer in stage I-II with or without radiotherapy. Strahlenther Onkol 2007, 183:679-684.
92. Prager R.L., Foster J.M., Hainsworth J.D., et al. The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluation. Ann Thorac Surg 1984, 38(6):622-626.
93. Williams C.J., McMillan I., Lea R., et al. Surgery after initial CT for localized small-cell carcinoma of the lung. J Clin Oncol 1987, 5(10):1579-1588.
94. Johnson D.H., Einhorn L.H., Mandelbaum I., et al. Post CT resection of residual tumor in limited stage small cell lung cancer. Chest 1987, 92(2):241-246.
95. Baker R.R., Ettinger D.S., Ruckdeschel J.D., et al. The role of surgery in the management of selected patients with small-cell carcinoma of the lung. Oncol 1987, 5(5):697-702.
96. Hara N., Ohta M., Ichinose Y., et al. Influence of surgical resection before and after CT on survival in small cell lung cancer. J Surg Oncol 1991, 47(1):53-61.
97. Zatopek N.K., Holoye P.Y., Ellerbroek N.A., et al. Resectability of small-cell lung cancer following induction CT in patients with limited disease (stage II-IIIb). Am J Clin Oncol 1991, 14(5):427-432.
98. Wada H., Yokomise H., Tanaka F., et al. Surgical treatment of small cell carcinoma of the lung: advantage of preoperative CT. Lung Cancer 1995, 13(1):45-56.
99. Fujimori K., Yokoyama A., Kurita Y., et al. A pilot phase 2 study of surgical treatment after induction CT for resectable stage I to IIIA small cell lung cancer. Chest 1997, 11:1089-1093.
100. Lewiński T., Zuławski M., Turski C., et al. Small cell lung cancer I-III A: cytoreductive CT followed by resection with continuation of CT. Eur J Cardiothorac Surg 2001, 20(2):391-398.
101. Nakamura H., Kato Y., Kato H. Outcome of surgery for small cell lung cancer. Response to induction CT predicts survival. Thorac Cardiovasc Surg 2004, 52:206-210.
102. Veronesi G., scanagatta P., Leo F., et al. Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer. J Thorac Oncol 2007, 2:131-134.
103. Yuequan J., Zhi Z., Chenmin X. Surgical resection for small cell lung cancer: pneumonectomy versus lobectomy. ISRN Surg 2012, 2012:101024. [abstract].
104. Veronesi G., Solli P.G., Leo F., et al. Low morbidity of bronchoplastic procedures after CT for lung cancer. Lung Cancer 2002, 36:91-97.
105. Leo F., Pastorino U. Surgery in small cell lung carcinoma. Where is the rationale?. Semin Surg Oncol 2003, 21:176-181.
106. Riquet M., Le Pimpec Barthes F., Scotté F., et al. Relevance of surgery in small cell lung cancer. Rev Pneumol Clin 2009, 65:129-135.
107. Granetzny A., Boseila A., Wagner W., et al. Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival. Eur J Cardiothorac Surg 2006, 30(2):212-216.
108. Hanagiri T., Sugio K., Baba T., et al. Results of surgical treatment for patients with small cell lung cancer. J Thorac Oncol 2009, 4:964-968.
109. Gridelli C., D'Aprile M., Curcio C., et al. Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI). Lung Cancer 1994, 11:83-91.
110. Eberhardt W., Stamatis G., Stuschke M., et al. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stage Ib to IIIB: long-term results of a phase II trial. Br J Cancer 1999, 81:1206-1212.
111. Benfield G.F., Matthews H.R., Watson D.C., et al. Chemotherapy plus adjuvant surgery for local small cell lung cancer. Eu J Surg Oncol 1989, 15:341-345.